IFN-γ and TNF-α, known to inhibit tumor cell proliferation, attenuate tumor-associated angiogenesis, and hinder multistage carcinogenesis [27], were significantly upregulated after treatment, particularly in the combined therapy group (p < 0.01). Here, IFNG is linked to neoplasm.